Gene · 6921
NIH grants1,232
NIH grants whose papers are about the gene, through NIH's grant-paper links.
521 to 540 of 1,232
Download this page as JSON| Grant | Title | ELOC papers | Newest fiscal year |
|---|---|---|---|
| R03TR003308 | Targeting understudied kinases in cancer cell plasticity and drug resistance | 1 | 2020 |
| R21AI138589 | BCA2's modulation of NF-kB and its role in proviral latency | 1 | 2020 |
| R21AI147163 | Viral manipulation of neuronal microRNAs to maintain trophic support and HSV latency | 1 | 2020 |
| R24DK106766 | VISION: ValIdated Systematic IntegratiON of epigenomic data | 1 | 2020 |
| R25GM062459 | Initiative for Maximizing Student Development | 1 | 2020 |
| R35DE027556 | Exploring roles of protein deamidation in oral inflammation | 1 | 2020 |
| S10OD028450 | Opera Phenix High-Content Imaging System for Drug Discovery | 1 | 2020 |
| S10OD028504 | An AVANCE NEO 400 MHz NMR Spectrometer for Chemical Biology and Drug Discovery | 1 | 2020 |
| T32CA009156 | Integrated Training in Cancer Model Systems | 1 | 2020 |
| U24CA204817 | Informatics Tools for High-throughput Analysis of Cancer Mutations | 1 | 2020 |
| U24CA210985 | The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets | 1 | 2020 |
| U24CA211006 | Deep Discovery and Clinical Interpretation of Germline and Somatic Cancer Drivers | 1 | 2020 |
| U54CA193313 | Topology of Cancer Evolution and Heterogeneity | 1 | 2020 |
| U54CA193461 | Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies | 1 | 2020 |
| U54HD090255 | Boston Intellectual and Developmental Disabilities Research Center | 1 | 2020 |
| U54NS100717 | Linking tau proteostasis with neuronal activity in FTD | 1 | 2020 |
| R01AI120694 | Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages | 5 | 2019 |
| T32GM007223 | Predoctoral Program in Cellular and Molecular Biology | 5 | 2019 |
| R01AI116313 | Recognition of Viral DNA by APOBEC3 Proteins and their Antagonization by HIV Vif | 4 | 2019 |
| R01CA082036 | Genetic and Biochemical Studies of KSHV LANA | 4 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6921/grants?page=27